- $189.44m
- $25.87m
- $60.20m
- 77
- 40
- 82
- 73
Annual income statement for Perfect, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 29.9 | 40.8 | 47.3 | 53.5 | 60.2 |
| Cost of Revenue | |||||
| Gross Profit | 25.9 | 35 | 40.2 | 43.1 | 46.9 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 32.7 | 45.8 | 118 | 59.2 | 63.3 |
| Operating Profit | -2.84 | -5.04 | -71.1 | -5.66 | -3.14 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.21 | -156 | -161 | 5.53 | 4.29 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.59 | -157 | -162 | 5.42 | 5.02 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -5.59 | -157 | -162 | 5.42 | 5.02 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -5.59 | -157 | -162 | 5.42 | 5.02 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.047 | -1.55 | -0.977 | 0.046 | 0.051 |
| Dividends per Share |